发明名称 A NEW PHARMACEUTICAL COMPOSITION
摘要 The invention relates to a composition comprising a first component (a) whic h is (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5- carboxamide in the form of the free base, pharmaceutically acceptable salts and/or solvates thereof, and a second component (b) which is a monoamine oxidase (MAO) inhibitor in the form of the free base, pharmaceutically acceptable salts and/or solvates thereof, the preparation thereof, pharmaceutical formulations containing said composition, a kit containing sa id composition, use of and a method of treatment of affective disorders such as mood disorders and anxiety disorders with said composition.
申请公布号 CA2349402(A1) 申请公布日期 2000.06.08
申请号 CA19992349402 申请日期 1999.11.23
申请人 ASTRAZENECA AB 发明人 THORBERG, SETH-OLOV;ROSS, SVANTE
分类号 A61K45/00;A61K31/15;A61K31/35;A61K31/353;A61K31/535;A61K31/5375;A61P25/22;A61P25/24;A61P43/00;(IPC1-7):A61K31/35 主分类号 A61K45/00
代理机构 代理人
主权项
地址